{"name":"GTx","slug":"gtx","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxNcDZzMHZBNjdhcVZ1WnItNVlNbjRzWWFJdDZ1MlhSLWR5cjRJbUxFWU5zaXBqV042aEU1NUEyTXlkelJyZjhYNTZES1VCTTRla1NGSXlOMGxGR2tTbHQzZEhHNXppenJCb2ZEa2hJa0pYOTFrazVNeHZkeFFFdEYtTFZLWlIwZjdlZVMxdGZERFQ2aVJEWU9QclBITlJhSnc?oc=5","date":"2025-11-10","type":"deal","source":"BioPharma Dive","summary":"Lilly picks up an eye gene therapy in deal with MeiraGTx - BioPharma Dive","headline":"Lilly picks up an eye gene therapy in deal with MeiraGTx","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxQeE1SVHI3Nk5LRi1SSzlPVlJsVGRYcU1uWjE3SzJkX1JDdWwzWG9nRWZHU3pPZGZwdDVPTnZ4Yy1aN3NYYU5QZVVSUUFYbjhORldGQkNqOHVFdjNVU0hGYU0xME5UUUU0QzVSTDdvTEllSzR1YldjWUFoX0tuZTRod1RUbnk5UmhtRmxxUTVzR284LUxxUE4zeA?oc=5","date":"2025-10-23","type":"pipeline","source":"Seeking Alpha","summary":"Garrett Motion Took Shareholders On A Heck Of A Ride - Seeking Alpha","headline":"Garrett Motion Took Shareholders On A Heck Of A Ride","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxOQVBaMFdYTGNFUTBDWFY5cXMzU3ZBUXVURHBDY3dfSVhoNTlhU3pxM01MLTJtUmtLbUNKUTZuSkh4Q0xfX1RnUXNNRzRkUWpWckV6TGVZSmJaOWtHN3pLazRzeGRmcmlxbVQya0ttdVFQWWVEcW9GZ2pNUDlyWU1CTWJTcG5lbGIxTG5SNGozNkJreDR1MTBMVkxfbEF0VUVoaUdvZ3h2My1jc19zU3REcDRwSFk?oc=5","date":"2025-06-25","type":"pipeline","source":"neurologylive.com","summary":"Grace Therapeutics Submits NDA for GTX-104 to Treat Aneurysmal Subarachnoid Hemorrhage - neurologylive.com","headline":"Grace Therapeutics Submits NDA for GTX-104 to Treat Aneurysmal Subarachnoid Hemorrhage","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE9UcDhyNkNlZWdLMzJBVXFCYkRpRGl0U29uZVU3RXpCbUN5ZkVPREV3MDcwaGR5aTN5TWFaYlFxNXdqY09rbjFlZG1OeTRzQ2hUeVlR?oc=5","date":"2025-04-15","type":"deal","source":"FirstWord Pharma","summary":"Roche's castoff Angelman drug gets second life in Oak Hill deal - FirstWord Pharma","headline":"Roche's castoff Angelman drug gets second life in Oak Hill deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMic0FVX3lxTE5vaXZvSXlLUHBrNGNzZy11RWJIUzk4UVZreTdFOTNRR2phMDNuRnlReDBBMXh1aVd4WGpFaWhZSUF3R3NtRF9qVjVfSFlDUGZJQl9aTHdvVzI5TFdMZ1o0Z1FMQXRBaFdKbnZZT29jY2pwOXc?oc=5","date":"2025-02-11","type":"pipeline","source":"Pharmaceutical Technology","summary":"Grace to secure $15m to fund GTx-104’s development - Pharmaceutical Technology","headline":"Grace to secure $15m to fund GTx-104’s development","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxQOWRBZkFOMXVDdHlET2cyNmdvZTNPbEFON0lJd1BOUmdJRklFQ3VFd0c1U0JiQjg4cDJSamZpeXhUUERZMVl3Nk5pSFdSaXdkZV9LUExJV25OZVYyQ0J3UVd6SkxqdGN4QVBfbGV4c0ZQSWREUUZoc0UyY2NGbGhBeV9MRE44SVY4NnNqQQ?oc=5","date":"2024-10-30","type":"pipeline","source":"NVIDIA Developer","summary":"High Throughput AI-Driven Drug Discovery Pipeline | NVIDIA Technical Blog - NVIDIA Developer","headline":"High Throughput AI-Driven Drug Discovery Pipeline | NVIDIA Technical Blog","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxNWHNSX3Bvb2RtYUlzSTlJSS1FOGdQZDN6Tm1FZWJiUEhmQlU5QmRoZlJvbTFuV2FEVU5qa0F0dUFxQVJHOW9vZ1NXYnBzSk52bWZGdzFzbmt2dV9ONFc3TFU3Y1JOVGFPUm5fdVBRVzc4YXN4RHk3MDNUTEFmM1FhLVFmbWp4emNCeFV4U3Y2YXlxM2ZrNjRvclJ4bVBqVUdlSEJ3d2R3TGpPMlpYZ0tOLUZBWHVoTWt6?oc=5","date":"2023-06-23","type":"regulatory","source":"Fierce Biotech","summary":"Weeks after laying off 'substantially all' employees, Acasti Pharma insists its approval plans remain on track - Fierce Biotech","headline":"Weeks after laying off 'substantially all' employees, Acasti Pharma insists its approval plans remain on track","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxQbUxNNmVvd19CcnpxTFRZcG0wZG5fNzhGbmZnVEIzUGdJQUlZYWR6RmNfT3pjdDJ4UnRESEtKVDhQUFhtUG96bUJBeUQzd2J0c2IwUGlzTlg4bnlsZHVXYXM2NkVkbDZvRV9Keks1UF9JS3JTYkhncjZ3QTJmSEg5YTRlZ25vYlU1ZzgzQ2xETVgydkt3S0tVTzVBMGMxLXh0Rkd1WC0tRG81SFdCXzgyaUJFWUVWSzBP?oc=5","date":"2023-01-03","type":"trial","source":"Fierce Pharma","summary":"Acasti, seeking to expand use of old steroid, posts clinical data on oral spray in rare disease - Fierce Pharma","headline":"Acasti, seeking to expand use of old steroid, posts clinical data on oral spray in rare disease","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiekFVX3lxTE5OcG9nNmtzN2ZFU29NU2I3a2ZTWGF4T2d4TGVCVlpsN3RuMTdxcHpGNlhWNHdBdkoxVDJLWXcwTlNFUXNzZW9wWFFXbkxOeUI3VW9fRldycEpjemFTajVGYkpvLU1mQk9ORFc4LXFmVmZkSTJJcmdDbmxR?oc=5","date":"2022-01-09","type":"pipeline","source":"Pharma Voice","summary":"One Step Ahead -- Dr. Mitchell S. Steiner - Pharma Voice","headline":"One Step Ahead -- Dr. Mitchell S. Steiner","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxNSzJ6eGpIRUhHTnA1cHducFdsX0djUU53VEl4bjh4QUdjZjE1VGhMTFhnN0p1ektORFFHWGR6enR4b1JoZXJCLWk3elhIVWdEbnh6TjVjWUZ6Y3huN1pOaEt6TUhiV19nZ3E0Q1d1aERxQ2RLcVY2LXJIZnBXUDJjVjZJN3dLMnV5VGlkNlh6M0ctZ2lLbTAwbGZLNnA2RjR2VDhQWXV1R054X3JFbmZSV28xWXhlQ1pRcGc?oc=5","date":"2020-07-08","type":"deal","source":"Ultragenyx","summary":"Ultragenyx Announces Partnership with GeneTx to Advance Treatment for Angelman Syndrome - Ultragenyx","headline":"Ultragenyx Announces Partnership with GeneTx to Advance Treatment for Angelman Syndrome","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizAFBVV95cUxOT1FPVjgyWG9fck0ybnRMOWliMDJlX2w4b2VRYWstRmoxejF1Wk5NMGswWUJqMUEtMGhLd3NWNDJDYW9rZjk1SDByWjNneVZoVm4zRTlOWmFvMGJST3FjRGlMbWVnbjBJZGQzOUVuUGlHTVhLTTlVSnJHdmdZUG9Pb0VvdmFna3NNeWFhRGZHekRyeXZrR0xiNm0wZmJ0dzhVYlUyZ0hXY05POGJCNGM3MF9IN01XQ3dEalpMeGRETDBaazdGZDJVUmtFZmk?oc=5","date":"2019-06-10","type":"deal","source":"globenewswire.com","summary":"Oncternal Therapeutics Completes Reverse Merger with GTx, Inc. - globenewswire.com","headline":"Oncternal Therapeutics Completes Reverse Merger with GTx, Inc.","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxNeGZnWVFNUjhCZkJEMlJRWHBHcndnSW03TWlicEotOWRtS25uMG44Uld3ZmUxd1VhYlNzMThnNzNSSnEzalp1YkZXUGdFeGp4Q0c0MjI0LVAtVXU1eXBSQXBtNkJ4amdZVkpMbUxQSU1DclNIUTdyZEVVRHU3NkV2dzI2ZDljVG9vVEVLNmpKTQ?oc=5","date":"2018-09-21","type":"pipeline","source":"The Motley Fool","summary":"Here's Why GTx, Inc. Dropped Over 92% Today - The Motley Fool","headline":"Here's Why GTx, Inc. Dropped Over 92% Today","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}